Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Am J Transplant. 2023 Jan 19;23(4):559–564. doi: 10.1016/j.ajt.2022.12.019

Figure 1:

Figure 1:

Flowchart of study design. Patients with missing DSA, CLAD or Death data were excluded (n=96). Patients with pre-formed DSA and those that did not develop DSA were then excluded, leaving 145 patients in our final analysis – 30 that received early treatment and 115 that did not receive early treatment. CLAD: Chronic Lung Allograft Dysfunction; DSA: Donor Specific Antibody.